Search Results - "Day, J.W"

The science of hypoxia in the Northern Gulf of Mexico: A review by Bianchi, T.S., DiMarco, S.F., Cowan, J.H., Hetland, R.D., Chapman, P., Day, J.W., Allison, M.A.

“…The Mississippi River is one of the world's 10 largest rivers, with average freshwater discharge into the northern Gulf of Mexico (GOM) of 380 km 3 year − 1 …”
Get full text

Is cardiac dysfunction a feature of dysferlinopathy? Data from the Clinical Outcome Study of Dysferlinopathy by Tiet, M., Fernandez-Torrón, R., Bourke, J., Bettinson, K., Harris, E., Hilsden, H., Spuler, S., Day, J.W., Jones, K.J., Bharucha-Goebel, D.X., Salort-Campana, E., Pestronk, A., Walter, M.C., Paradas, C., Stojkovic, T., Mori-Yoshimura, M., Bravver, E., Diaz Manera, J., Pegoraro, E., Mendell, J.R., Bushby, K., Straub, V.

Get full text

Insulin Receptor Splicing Alteration in Myotonic Dystrophy Type 2 by Savkur, R.S., Philips, A.V., Cooper, T.A., Dalton, J.C., Moseley, M.L., Ranum, L.P.W., Day, J.W.

“…Myotonic dystrophy (DM) is caused by either an untranslated CTG expansion in the 3′ untranslated region of the DMPK gene on chromosome 19 (dystrophia myotonica…”
Get full text

G.P.167 by Connolly, A.M, Malkus, E.C, Schierbecker, J.R, Siener, C.A, Anand, P, Mendell, J.R, Flanigan, K.M, Golumbek, P.T, Zaidman, C.M, McDonald, C.M, Henricson, E, Johnson, L, Nicorici, A, Karachunski, P.I, Day, J.W, Kelecic, J.M, Lowes, L.P, Alfano, L.N, Darras, B.T, Kang, P.B, Florence, J.M

“…Few clinical trials involve non-ambulatory boys and men with Duchenne muscular dystrophy. We previously tested clinical outcomes in 91 subjects and found…”
Get full text

P.7.16 One year outcome assessment of young boys with DMD using the Bayley-III Scales of Infant and Toddler Development by Connolly, A.M, Florence, J.M, Cradock, M.M, Malkus, E.C, Schierbecker, J.R, Siener, C.A, Wulf, C.O, Anand, P, Golumbek, P.T, Zaidman, C.M, Lowes, L.P, Alfano, L.N, Viollet-Callendret, L, Flanigan, K.M, Mendell, J.R, McDonald, C.M, Goude, E, Johnson, L, Nicorici, A, Karachunski, P.I, Day, J.W, Dalton, J.C, Farber, J.M, Buser, K.K, Darras, B.T, Kang, P.B, Riley, S.O, Shriber, E, Parad, R, Bushby, K, Eagle, M, DMD, M.D.A

“…Clinical trials currently underway in Duchenne muscular dystrophy (DMD) almost always exclude infants and young boys because traditional outcome measures rely…”
Get full text

A 7 year record of above-ground net primary production in a southeastern Mexican mangrove forest by Day, J.W., Coronado-Molina, Carlos, Vera-Herrera, F.R., Twilley, R., Rivera-Monroy, V.H., Alvarez-Guillen, H., Day, R., Conner, W.

“…Spatial and temporal variations in net above-ground primary production (NPP) and litter turnover rate were studied, from 1987 to 1993, in a mangrove forest…”
Get full text

Mississippi river sediment diversions and coastal wetland sustainability: Synthesis of responses to freshwater, sediment, and nutrient inputs by Elsey-Quirk, T., Graham, S.A., Mendelssohn, I.A., Snedden, G., Day, J.W., Twilley, R.R., Shaffer, G., Sharp, L.A., Pahl, J., Lane, R.R.

“…Management and restoration of coastal wetlands require insight into how inundation, salinity, and the availability of mineral sediment and nutrients interact…”
Get full text

RWD166 Comparative Real-World Retrospective Data Analysis of Comorbid Conditions and Healthcare Utilization for Patients with Myotonic Dystrophy over a 5-Year Timeframe by Day, J.W, Chen, C.Y, Munoz, K., Brook, R.A, Kleinman, N.L, McEvoy, B., Cho, H., Stahl, M., Tai, L.J

Get full text

Major Adverse Dystrophinopathy Event Score as Marker of Cumulative Morbidity and Risk for Mortality in Boys with Duchenne Muscular Dystrophy by Kaufman, B.D., Garcia, A., He, Z., Buu, M., Tesi-Rocha, C., Day, J.W., Rosenthal, D.N., Gordish-Dressman, H., Almond, C., Duong, T.

“…Accurate assessments of heart failure (HF) severity in Duchenne Muscular Dystrophy (DMD) is challenging due to overlapping symptoms from cardiomyopathy,…”
Get full text

Ecogeomorphology of coastal deltaic floodplains and estuaries in an active delta: Insights from the Atchafalaya Coastal Basin by Twilley, R.R., Day, J.W., Bevington, A.E., Castañeda-Moya, E., Christensen, A., Holm, G., Heffner, L.R., Lane, R., McCall, A., Aarons, A., Li, S., Freeman, A., Rovai, A.S.

“…We present here an integrated analysis of coastal deltaic floodplains in the active Atchafalaya Coastal Basin coupled to downstream deltaic estuaries to review…”
Get full text

Interactions among science, environmental policy and public perception in a Mississippi River Delta assimilation wetland by Day, J.W., Hunter, R.G., Jafari, N., Ko, J.-Y., Lane, R.R., Shaffer, G.P., Wallace, S.D.

“…In November 2006, the City of Hammond, Louisiana, began discharging secondarily treated, disinfected municipal effluent through a distribution pipeline to a…”
Get full text

Longitudinal pulmonary function testing outcome measures in Duchenne muscular dystrophy: Long-term natural history with and without glucocorticoids by McDonald, Craig M., Gordish-Dressman, Heather, Henricson, Erik K., Duong, Tina, Joyce, Nanette C., Jhawar, Sanjay, Leinonen, Mika, Hsu, Fengming, Connolly, Anne M., Cnaan, Avital, Abresch, Richard T., Dubrovsky, A., Kornberg, A., Ryan, M., Webster, R., Biggar, W.D., McAdam, L.C., Mah, J.K., Kolski, H., Vishwanathan, V., Chidambaranathan, S., Nevo, Y., Gorni, K., Carlo, J., Tulinius, M., Lotze, T., Bertorini, T.E., Day, J.W., Karachunski, P., Clemens, P.R., Abdel-Hamid, H., Teasley, J., Kuntz, N., Driscoll, S., Bodensteiner, J.B., Connolly, A.M., Pestronk, A., Abresch, R.T., Henricson, E.K., Joyce, N.C., McDonald, C.M., Cnaan, A., Morgenroth, L.P., Leshner, R., Tesi-Rocha, C., Thangarajh, M., Duong, T.

“…•Natural history changes in pulmonary function tests across time in Duchenne muscular dystrophy.•Treatment with glucocorticoids (steroids) > 1 year was…”
Get full text

Applications and utility of the surface elevation table–marker horizon method for measuring wetland elevation and shallow soil subsidence-expansion: Discussion/reply to: Byrnes M., Britsch L., Berlinghoff J., Johnson R., and Khalil S. 2019. Recent subsidence rates for Barataria Basin, Louisiana. Geo-Marine Letters 39:265–278 by Cahoon, D.R., Reed, D.J., Day, J.W., Lynch, J.C., Swales, A., Lane, R.R.

“…Byrnes et al. (Geo-Marine Letters 39:265–278, Byrnes et al. 2019 ) present subsidence data for Barataria Basin located south and west of New Orleans in coastal…”
Get full text

The restore registry: A resource for measuring and improving spinal muscular atrophy outcomes by Servais, L., Day, J.W., De Vivo, D.C., Kirschner, J., Mercuri, E., Muntoni, F., Shieh, P.B., Tizzano, E., Droege, M., Dabbous, O., Khan, F., Anderson, F.A., Finkel, R.S.

Get full text

Basin-scale land use impacts on world deltas: Human vs natural forcings by Ibáñez, C., Alcaraz, C., Caiola, N., Prado, P., Trobajo, R., Benito, X., Day, J.W., Reyes, E., Syvitski, J.P.M.

“…A new global database of 86 deltas and river basins was analyzed to investigate the relative importance of deforestation and land use changes versus natural…”
Get full text

Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy by ESCOLAR, D. M, HACHE, L. P, PESTRONK, A, RYAN, M. M, MONASTERIO, E, DAY, J. W, ZIMMERMAN, A, ARRIETA, A, HENRICSON, E, MAYHEW, J, FLORENCE, J, HU, F, CLEMENS, P. R, CONNOLLY, A. M, CNAAN, A, MCDONALD, C. M, VISWANATHAN, V, KORNBERG, A. J, BERTORINI, T. E, NEVO, Y, LOTZE, T

“…To perform a double-blind, randomized study comparing efficacy and safety of daily and weekend prednisone in boys with Duchenne muscular dystrophy (DMD). A…”
Get full text

Clinical features of facioscapulohumeral muscular dystrophy 2 by DE GREEF, J. C, LEMMERS, R. J. L. F, DESNUELLE, C, SPULER, S, TARNOPOLSKY, M, VENANCE, S. L, FRANTS, R. R, VAN DER MAAREL, S. M, TAWIL, R, CAMANO, P, DAY, J. W, SACCONI, S, DUNAND, M, VAN ENGELEN, B. G. M, KIURU-ENARI, S, PADBERG, G. W, ROSA, A. L

“…In some 5% of patients with facioscapulohumeral muscular dystrophy (FSHD), no D4Z4 repeat contraction on chromosome 4q35 is observed. Such patients, termed…”
Get full text

Intrathecal administration of AVXS-101 gene-replacement therapy (GRT) for spinal muscular atrophy type 2 (SMA2): Phase 1/2A study (strong) by Finkel, R.S., Day, J.W., Darras, B.T., Kuntz, N.L., Connolly, A.M., Crawford, T.O., Butterfield, R.J., Shieh, P.B., Tennekoon, G., Iannaccone, S.T., Meriggioli, M., Ogrinc, F.G., Kavanagh, S., Kernbauer, E., Whittle, J., L'Italien, J., Kaspar, B., Sproule, D.M., Spector, S.A., Feltner, D.E., Mendell, J.R.

Get full text

Onasemnogene abeparvovec gene-replacement therapy (GRT) for spinal muscular atrophy type 1 (SMA1): Global pivotal phase 3 study program (STR1VE-US, STR1VE-EU, STR1VE-AP) by Mercuri, E., Baranello, G., Day, J.W., Bruno, C., Corti, S., Chiriboga, C.A., Crawford, T.O., Darras, B.T., Finkel, R.S., Connolly, A.M., Iannaccone, S.T., Kuntz, N.L., Masson, R., Peña, L.D.M., Baldinetti, F., Schultz, M., Shieh, P.B., Smith, E.C., Saito, K., Scoto, M., Spector, S.A., Truncated, A. Authors, Sproule, D.M., Mendell, J.R., Muntoni, F.

Get full text

The clinical outcome study of dysferlinopathy: Muscle MRI pattern at baseline and longitudinal changes over one year by Mori-Yoshimura, M., Fernandez-Torrón, R., Meredith, J., Jabobs, M., Smith, F., Azzabou, N., Manera, J.D., Spuler, S., Day, J.W., Jones, K.J., Bharucha-Goebel, D.X., Salort-Campana, E., Pestronk, A., Walter, M.C., Paradas, C., Stojkovic, T., Bravver, E., Pegoraro, E., Mendell, J.R., Straub, V.

Get full text